Immunopeptidomics offer new hope in cancer research

In this new omg OMx podcast episode, Bruker’s Kate Stumpo speaks to Nicola Ternette on the incredible world of immunopeptidomics – the implications they could have for research and how they help us
understand the immune system better.

Cybin to Participate in PSYCH Symposium London 2023 | Psychedelic Invest

-Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to

June 30, 2023

Editas to cut 65% of workforce, officially stops work on ex vivo sickle cell therapy

Editas Medicine will eliminate about 180 roles after failing to find a commercial partner for its experimental sickle cell therapy, and will halt development of

December 13, 2024

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Promising results with an investigational CAR T-cell therapy in triple-negative breast cancer and non-small cell lung cancer (NSCLC) were tempered by an unexplained death in

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.